Biomarkers of Progression and Risk Stratification in Asymptomatic Waldenström Macroglobulinemia
Hematology/Oncology Clinics of North America · 2023
DOI: 10.1016/j.hoc.2023.06.012 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Hematology/Oncology Clinics of North America, 2023. Verfasst von Mark Bustoros und 3 weiteren Autor:innen. Beteiligte Einrichtung: Division of Hematology and Medical Oncology, Department of Medicine, Weill Cornell Medicine, NewYork-Presbyterian Hospital, New York, NY, USA. Electr…. Hauptthemen laut MEDLINE: Waldenstrom Macroglobulinemia, Biomarkers, Tumor. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 37 Literaturangaben.
Abstract (Originalsprache)
Waldenström macroglobulinemia is an indolent IgM-secreting B-cell lymphoplasmacytic lymphoma that is preceded by an asymptomatic stage. Clinical and molecular features have been used in risk models to predict progression rates in different asymptomatic subgroups. Risk models used both disease-specific and nonspecific biomarkers for asymptomatic patients. Recently, models that incorporate continuous variables rather than distinct cutoffs have emerged to more accurately predict the risk of progression. Integrating genetic alterations to the clinical models is a promising approach that could improve risk stratification and management of asymptomatic patients.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Division of Hematology and Medical Oncology, Department of Medicine, Weill Cornell Medicine, NewYork-Presbyterian Hospital, New York, NY, USA. Electronic address: mab4033@med.cornell.edu.
- Division of Hematology and Medical Oncology, Department of Medicine, Weill Cornell Medicine, NewYork-Presbyterian Hospital, New York, NY, USA.
- Bing Center for Waldenström Macroglobulinemia, Dana-Farber Cancer Institute, Boston, MA, USA.
Zitieren
APA
Bustoros, M., Gribbin, C., Castillo, J. J., & Furman, R. (2023). Biomarkers of Progression and Risk Stratification in Asymptomatic Waldenström Macroglobulinemia. Hematology/Oncology Clinics of North America. https://doi.org/10.1016/j.hoc.2023.06.012
Vancouver
Bustoros M, Gribbin C, Castillo JJ, Furman R. Biomarkers of Progression and Risk Stratification in Asymptomatic Waldenström Macroglobulinemia. Hematology/Oncology Clinics of North America. 2023. doi:10.1016/j.hoc.2023.06.012
BibTeX
@article{Bustoros2023,
author = {Bustoros, Mark and Gribbin, Caitlin and Castillo, Jorge J and Furman, Richard},
title = {Biomarkers of Progression and Risk Stratification in Asymptomatic Waldenström Macroglobulinemia},
journal = {Hematology/Oncology Clinics of North America},
year = {2023},
doi = {10.1016/j.hoc.2023.06.012}
}
EUVIMED